Prot# 156-04-251: A Phase 3, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Arm Trial to Determine Long-Term Safety and Efficacy of Oral Tolvaptan Tablet Regimens in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease

Project: Research project

StatusFinished
Effective start/end date9/4/079/4/10

Funding

  • Parexel (156-04-251)
  • Otsuka Maryland Research Institute, Inc. (156-04-251)